| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Nephrology and Hypertension (H.P.H.N., B.U.B.), Department of Gastroenterology and Endocrinology (M.R.), Albert-Ludwigs-University, D-79106 Freiburg, Germany; Department of Pediatrics (R.E.), Maximilian-University, D-80337 Munich, Germany; Department of Urology (G.J.) Leopold-Franzens-University, A-6020 Innsbruck, Austria
Address correspondence and requests for reprints to: Professor Dr. H. P. H. Neumann, Medizinische Universitätsklinik, Hugstetter Straße 55, D-79106 Freiburg, Germany. E-mail:
| Abstract |
|---|
|
|
|---|
Patients and methods: Four patients (three male, one female, ages 960 yr) with hereditary bilateral adrenal pheochromocytoma were treated by laparoscopic surgery in an organ sparing fashion. Postoperatively, all patients were reevaluated for complete tumor removal and for adrenocortical function.
Results: Two to 24 months after surgery, all patients were normotensive, had normal sodium potassium, glucose, aldosterone, renin, and cortisol serum concentrations, 24-h excretion of norepinephrine, epinephrine, and vanillylmandelic acid. Abdominal magnetic resonance imaging (n = 3) and computed tomographic scan (n = 1) disclosed no remnant or relapsing tumor tissue. ACTH stimulation testing resulted in normal cortisol responses.
Conclusion: By adrenal sparing laparoscopic surgery not only bilateral pheochromocytoma can be successfully removed, but also adrenocortical function preserved. This may become the treatment of choice for familial pheochromocytoma.
| Introduction |
|---|
|
|
|---|
| Patients and Methods |
|---|
|
|
|---|
|
| Results |
|---|
|
|
|---|
|
|
| Discussion |
|---|
|
|
|---|
Within a short period of time, minimally invasive surgery using endoscopic techniques has been adopted by numerous medical centers worldwide and has gained wide acceptance among endocrine surgeons for the resection of adrenal tumors (10). Although prospective, randomized studies are lacking, laparoscopic adrenalectomy seems to be associated with a significantly shorter hospital stay, less postoperative narcotic use, increased patient satisfaction and reduced late morbidity (11). However, the laparascopic procedure was associated with longer operation time and higher costs (6). Laparoscopic surgery is now recommended for benign adrenal lesions not exceeding 6 cm in diameter, whereas larger and potentially malignant adrenal masses should be removed by open surgery (10).
In bilateral pheochromocytoma which occurs mainly in Von Hippel-Lindau disease or in multiple endocrine neoplasia type 2, both, conventional and laparoscopic adrenalectomy result in permanent adrenal insuffiency requiring life long steroid replacement therapy. This may have serious health implications including osteoporosis due to chronic hydrocortisone oversubstitution, impaired quality of life and symptoms of hypoandrogenism in women due to missing adrenal androgen production. We therefore offered patients with hereditary pheochromocytoma adrenal sparing surgery as an alternative to a total adrenalectomy, avoiding steroid dependency. Because malignancy is extremely rare in familial pheochromocytoma and does not pose a major problem, we considered this approach to be safe. Since 1985, we have treated 39 patients accordingly, including 14 patients with bilateral pheochromocytoma (5). All patients were cured from pheochromocytoma. Of the patients who underwent bilateral surgery, only one became chronically steroid dependent. These data show that open adrenal sparing surgery is a rather safe procedure and preserves adrenocortical function in most of the patients. This approach may be particularly justified in patients with bilateral or hereditary pheochromocytoma.
We now show that adrenal sparing surgery can also be performed using laparoscopic minimally invasive surgery. Because of the magnification provided by the endoscope, laparoscopy has the advantage of allowing better visualization of small vessels than open surgery, thus permiting meticulous preparation during resection. There is an increased risk of hypertensive crisis during partial adrenalectomy, as the adrenal vein cannot be ligated. Indeed, an instant increase in blood pressure has always been observed when the adrenal gland is approached. Nevertheless, hypertension could be easily controlled by pharmacological means in our studies and in the literature (8). Obviously, pretreatment with an alpha-blocker is very effective, and direct manipulation of the pheochromocytoma is tolerated without previous ligation of the adrenal vein.
Adrenocortical function was maintained in all patients as documented by normal ACTH stimulation tests. The time of follow-up is still to short to draw conclusions concerning the rate of pheochromocytoma recurrence, but for technical reasons it should not be higher than after open adrenal sparing surgery, with one recurrence in 29 patients after 6 yr mean follow-up (5). A disadvantage of the technique is the long operation time (mean, 8 hr). This is longer than the mean operation time of 6.5 hr in a recently published series of patients undergoing bilateral laparoscopic adrenalectomy (12) and considerably longer than that of open bilateral adrenalectomy. However, operation time was increased in our series due to extra-adrenal pheochromocytomas in 3 of 4 patients, which were removed in the same session successfully. On the other hand, even long operative times do not increase morbidity substantially, but recovery is essentially decreased after laparascopy as compared to open surgery (8, 11). Finally, patients will increasingly prefer laparascopic adrenal operations because of the excellent cosmetic results.
In summary, we show that bilateral laparoscopic and adrenal sparing surgery is technically feasable and maintains adrenocortical function in patients with hereditary pheochromocytoma. This approach should be considered especially in young patients who may otherwise face life long steroid replacement therapy.
| Footnotes |
|---|
Received February 24, 1999.
Revised April 14, 1999.
Accepted April 16, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. Asari, C. Scheuba, K. Kaczirek, and B. Niederle Estimated Risk of Pheochromocytoma Recurrence After Adrenal-Sparing Surgery in Patients With Multiple Endocrine Neoplasia Type 2A Arch Surg, December 1, 2006; 141(12): 1199 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. H. Neumann, C. Pawlu, M. Peczkowska, B. Bausch, S. R. McWhinney, M. Muresan, M. Buchta, G. Franke, J. Klisch, T. A. Bley, et al. Distinct Clinical Features of Paraganglioma Syndromes Associated With SDHB and SDHD Gene Mutations JAMA, August 25, 2004; 292(8): 943 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Baghai, G. B. Thompson, W. F. Young Jr, C. S. Grant, V. V. Michels, and J. A. van Heerden Pheochromocytomas and Paragangliomas in von Hippel-Lindau Disease: A Role for Laparoscopic and Cortical-Sparing Surgery Arch Surg, June 1, 2002; 137(6): 682 - 689. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |